Project documents | Aducanumab for treating mild cognitive impairment and mild dementia caused by Alzheimer's disease [ID3763] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 203 KB)

Published:

08 July 2021
Final stakeholder list (PDF 169 KB)

Published:

08 July 2021
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 463 KB)

Published:

08 July 2021
Equality impact assessment (Scoping) (PDF 127 KB)

Published:

08 July 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 207 KB)

Published:

22 September 2020
Draft matrix post referral (PDF 168 KB)

Published:

22 September 2020